Skip to main content
Log in

Plasmonic nanosensors

Inverse sensitivity

  • News & Views
  • Published:

From Nature Materials

View current issue Submit your manuscript

Enzyme-modified plasmonic nanoparticles that generate a signal that is larger when the concentration of the target molecule is lower can detect ultralow levels of the cancer biomarker prostate-specific antigen in whole serum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The inverse-sensitivity mechanism of enzyme-modified plasmonic nanosensors2.

References

  1. Engvall, E. & Perlmann, P. Immunochemistry 8, 871–874 (1971).

    Article  CAS  Google Scholar 

  2. Rodríguez-Lorenzo, L., de la Rica, R., Álvarez-Puebla, R. A., Liz-Marzán, L. & Stevens, M. M. Nature Mater. 11, 604–607 (2012).

    Article  Google Scholar 

  3. Lal, S., Link, S. & Halas, N. J. Nature Photon. 1, 641–648 (2007).

    Article  CAS  Google Scholar 

  4. Anker, J. N. et al. Nature Mater. 7, 442–453 (2008).

    Article  CAS  Google Scholar 

  5. Chen, S., Svedendahl, M., Van Duyne, R. P. & Käll, M. Nano Lett. 11, 1826–1830 (2011).

    Article  CAS  Google Scholar 

  6. Nehl, C. L., Liao, H. W. & Hafner, J. H. Nano Lett. 6, 683–688 (2006).

    Article  CAS  Google Scholar 

  7. Giljohann, D. A. & Mirkin, C. A. Nature 462, 461–462 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mikael Käll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Käll, M. Inverse sensitivity. Nature Mater 11, 570–571 (2012). https://doi.org/10.1038/nmat3365

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmat3365

  • Springer Nature Limited

This article is cited by

Navigation